Shockwave Announces Decisions From the U.S. Patent and Trademark Office on Inter Partes Review Proceeding
ShockWave Medical, Inc. (SWAV)
Last shockwave medical, inc. earnings: 2/13 04:03 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
SANTA CLARA, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company received the initial rulings related to two of the inter partes review (IPR) cases that were initiated by Cardiovascular Systems, Inc. (CSI). In December 2018, CSI filed petitions for IPR with the Patent Trial and Appeal Board (PTAB) of the U.S. Patent Office (USPTO) to challenge the validity of three of Shockwave’s issued patents. CSI asked the PTAB to reconsider the original decision of the USPTO to issue those patents and asked that all claims of each patent be invalidated. The PTAB ruled today that a key claim in U.S. Patent No 8,956,371 (the ‘371 patent) is valid. This claim is generally directed to a device that creates shockwaves inside of a balloon catheter that is delivered over a guidewire. Further, the PTAB ruled today that some
Show less
Read more
Impact Snapshot
Event Time:
SWAV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SWAV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SWAV alerts
High impacting ShockWave Medical, Inc. news events
Weekly update
A roundup of the hottest topics
SWAV
News
- SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAVBusiness Wire
- Averto Medical secures $30.5m to advance ColoSeal system [Yahoo! Finance]Yahoo! Finance
- Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares [Yahoo! Finance]Yahoo! Finance
- Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y Tue, May 7, 2024, 4:27 PM GMT+2 4 min read 0 Revenue Details Business Highlights Margins Financial Position 2024 Guidance Withdrawn Wrapping Up ShockWave Medical, Inc. Price, Consensus and EPS SAcquire Media Monitor
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
SWAV
Earnings
- 2/15/24 - Beat
SWAV
Sec Filings
- 5/6/24 - Form 10-Q
- 5/6/24 - Form 8-K
- 5/3/24 - Form 4
- SWAV's page on the SEC website